MODERN ASPECTS OF THE COURSE OF HEMOLYTIC DISEASES OF NEWBORNS IN KARAGANDA REGION
Abstract
The aim of our work was to analyze the frequency of occurrence, type of conflict, and features of the course of hemolytic disease of newborns at the present stage. We conducted a retrospective analysis of the medical histories of newborns born in 2019 in the LLP «RGC» of Karaganda. The analysis showed that the proportion of newborns with hemolytic disease for the analyzed period was 0.7%, the incidence rate was 7 per 1000 newborns born alive. ABO -isoimmunization was more than 10 times higher than Rh-isoimmunization in newborns. Timely diagnosis and treatment contributed to a favorable prognosis and the absence of complications. However, carrying out timely preventive measures for pregnant women prevents the birth of newborns with hemolytic disease.
About the Authors
F. H. IbragimovaKazakhstan
O. S. Baitureyev
Kazakhstan
G. N. Ramankul
Kazakhstan
L. A. Itkulova
Kazakhstan
S. T. Kizatova
Kazakhstan
References
1. Гемолитическая болезнь плода у беременных с резус-сенсибилизацией. Диагностика, лечение, профилактика: Методическое письмо Минздравсоцразвития /Г. М. Савельева, М. А. Курцер, О. Б. Панина и др. -М., 2012. - 18 с.
2. Избранные клинические рекомендации по неонатологии /Под ред. Е. Н. Байбариной, Д. Н. Дегтярева. - М.: ГЭОТАР-Медиа, 2016. - 322 c.
3. Клинический протокол диагностики и лечения гемолитической болезни плода и новорожденного //Протоколы диагностики и лечения заболеваний МЗ РК (Приказ №764 от 28.12.2007).
4. Кобзарь Н. Н. Проблема гемолитической болезни плода и новорожденного в Казахстане //Medicine. - 2014. - №11. - С. 5658.
5. Коноплянников А. Г. Изосерологическая несовместимость крови матери и плода. Гемолитическая болезнь плода и новорожденных /А. Г. Коноплянников, Н. Г. Павлова // Акушерство. Национальное руководство. - М., 2015. - С. 324-334.
6. An emergency medicine approach to neonatal hyperbilirubinemia /J. E. Colletti, S. Kothari, F. Kothori et al. //Emerg. Med. Clin. North Am. - 2017. - V. 25 (4). - P. 1117-1135.
7. Crowther C. Anti-D administration in pregnancy for preventing Rhesus alloimmumzation /C. Crowther, P. Middleton, R. McBain // Cochrane Database Syst. Rev. - 2013. - V. 2. -P. 134-137.
8. Delaney M. Hemolytic disease of fetus and newborn: managing the mother, fetus and newborn /M. Delaney, D. S. Matthews // Hematology Am. Soc. Hematol. Educ. Programme. - 2015. - V. 5 (l). - P. 146-151.
9. Harkness U. F. Prevention and management of RhD isoimmunization /U. F. Harkness, J. A. Spinnato //Clin. Perinatol. - 2004. - V. 31(4). -P. 721-742.
10. Nandyal R. R. Hemolytic disease of the newborn //J. Hematol. Thrombo Dis. - 2015. - V. 3. - P. 203-205.
11. Neonatal management and outcome in alloimmune hemolytic disease /I. M. C. Ree, V. E. H. J. Smits-Wintjens, J. G. van der Bom et al. //Expert. Rev. Hematol. - 2017. - V. 10. - P. 607-616.
Review
For citations:
Ibragimova F.H., Baitureyev O.S., Ramankul G.N., Itkulova L.A., Kizatova S.T. MODERN ASPECTS OF THE COURSE OF HEMOLYTIC DISEASES OF NEWBORNS IN KARAGANDA REGION. Medicine and ecology. 2021;(1):24-29.
Email this article 